Skip to content
A2646Assembly2023-2024 Session

Require Informed Consent for Psych Drugs

Official title

“Requires a doctor to obtain the informed consent of patients prior to prescribing psychiatric drugs notifying the patient of possible adverse effects of the drug”

Sponsor Jake Ryan BlumencranzAD-15+5 co-sponsorsAffects Education
Status
In Assembly Committee
Higher Education
Impact
7/10
Significant
Passage
0%

Bill progress

Step 2 of 7

In committee · Higher Education

What's happening

This bill requires doctors to obtain signed informed consent from patients, including notification of adverse effects, before prescribing psychiatric drugs.

Why it matters

  1. Strengthens patient autonomy. By requiring signed informed consent, this bill ensures that patients have a clear understanding of the psychiatric drugs they are being prescribed, including potential risks and side effects, before beginning treatment.

  2. Could impact prescribing practices. Doctors will need to dedicate more time to patient education and documentation, possibly affecting the speed and process by which psychiatric medications are prescribed and increasing administrative responsibilities.

  3. May reduce medication-related harm. Explicit notification about adverse effects and drug interactions could help patients identify and report side effects sooner, potentially reducing instances of harm or complications from psychiatric medications.

  4. Legal and professional implications for doctors. The requirement for signed consent introduces new legal standards that, if not followed, could expose prescribers to liability or disciplinary action, thus raising the stakes for compliance with informed consent protocols.

The daily · weekday mornings

Albany, before your first meeting.

Every bill that moved yesterday, summarized in a sentence and ranked by impact. The Albany Scorecard follows on Sundays.

Free. Unsubscribe in one click. Want alerts on specific bills? Create an account.

Headline styles

Require Informed Consent for Psych Drugs

Plain English, a few words. Used as the page title.

Sponsors

Primary sponsor
Jake Ryan Blumencranz

Assembly Member · Assembly District 15

History

  1. Referred to higher education
  2. Referred to higher education

Full text

1 pageUnderlined is new[Struck] is removedOfficial text on nysenate.gov ↗

STATE OF NEW YORK

2646

2023-2024 Regular Sessions

IN ASSEMBLY

January 26, 2023

Introduced by M. of A. BLUMENCRANZ -- read once and referred to the Committee on Higher Education

AN ACT to amend the public health law, in relation to requiring notification and the informed consent of the patient prior to prescribing psychiatric drugs

The People of the State of New York, represented in Senate and Assembly, do enact as follows:

Section 1. The public health law is amended by adding a new section 3346 to read as follows:

§ 3346. Psychiatric drug informed consent. No doctor shall prescribe an antipsychotic, antidepressant, hallucinogen, or mood stabilizer drug, brand or generic, as defined in section thirty-three hundred six of this article, for the treatment of psychiatric disorders or conditions without the prior notification and the signed informed consent of the patient informing the patient of any possible adverse effects of the drug and the interaction with other medications the patient is currently prescribed.

§ 2. This act shall take effect immediately.

EXPLANATION--Matter in italics (underscored) is new; matter in brackets

[ ] is old law to be omitted.

LBD06905-01-3

Reflowed for reading: line numbers and page breaks removed. Cite the official text.

Summaries, headlines and scores are AI-generated from the official bill text. How we score bills. Source: NYS Open Legislation.